Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1456.92 | 180 / 180 | 100% | 9.44 | 430 / 430 |
pancreas | 100% | 907.09 | 328 / 328 | 100% | 11.85 | 178 / 178 |
thymus | 100% | 1783.14 | 653 / 653 | 100% | 10.62 | 604 / 605 |
lung | 100% | 4259.80 | 578 / 578 | 100% | 12.20 | 1153 / 1155 |
intestine | 100% | 1837.77 | 966 / 966 | 100% | 9.16 | 526 / 527 |
uterus | 100% | 1584.78 | 170 / 170 | 100% | 10.68 | 458 / 459 |
esophagus | 100% | 1173.18 | 1441 / 1445 | 100% | 9.20 | 183 / 183 |
kidney | 100% | 1513.34 | 89 / 89 | 100% | 11.60 | 898 / 901 |
stomach | 100% | 1162.94 | 359 / 359 | 99% | 9.73 | 284 / 286 |
bladder | 100% | 1508.95 | 21 / 21 | 99% | 10.12 | 500 / 504 |
prostate | 100% | 1743.68 | 244 / 245 | 100% | 7.27 | 500 / 502 |
breast | 100% | 1413.98 | 459 / 459 | 99% | 8.90 | 1105 / 1118 |
liver | 100% | 975.01 | 226 / 226 | 99% | 6.45 | 401 / 406 |
brain | 99% | 1218.31 | 2609 / 2642 | 100% | 17.27 | 705 / 705 |
adrenal gland | 100% | 1407.59 | 258 / 258 | 99% | 8.47 | 227 / 230 |
skin | 100% | 845.94 | 1800 / 1809 | 99% | 13.80 | 468 / 472 |
adipose | 100% | 1762.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 27.40 | 29 / 29 |
spleen | 100% | 8364.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.55 | 1 / 1 |
peripheral blood | 100% | 8078.03 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1211.42 | 1325 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 987.10 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 970.83 | 794 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 6.03 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0006914 | Biological process | autophagy |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0045087 | Biological process | innate immune response |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF166 |
Protein name | Ring finger protein 166 RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase RNF166 (EC 2.3.2.27) (RING finger protein 166) (RING-type E3 ubiquitin transferase RNF166) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that promotes the ubiquitination of different substrates . In turn, participates in different biological processes including interferon production or autophagy . Plays a role in the activation of RNA virus-induced interferon-beta production by promoting the ubiquitination of TRAF3 and TRAF6 . Also plays a role in the early recruitment of autophagy adapters to bacteria . Mediates 'Lys-29' and 'Lys-33'-linked ubiquitination of SQSTM1 leading to xenophagic targeting of bacteria and inhibition of their replication . . |
Accessions | ENST00000541206.6 [Q96A37-2] ENST00000562544.1 ENST00000537718.6 [Q96A37-2] ENST00000567408.1 ENST00000567844.1 [Q96A37-3] ENST00000568683.5 ENST00000312838.9 [Q96A37-1] H3BPZ9 H3BTX7 Q96A37 H3BQ58 |